Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q2 2024 · 10-Q
Revenue$11.52M$11.52M−57.1% vs Q2 2023 Net Income-$6.62M-$6.62MN/M vs Q2 2023 EPS Diluted-$1.41-$1.41N/M vs Q2 2023 Gross Profit$2,969,000−32.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,392,000N/M Free Cash Flowderived-$3,431,000— Margins · derivedGross margin25.8%+9.3 pt vs Q2 2023
Operating margin-56.2%−59.0 pt vs Q2 2023
Net margin-57.5%−59.3 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 9, 2024 · 40 d after period end